Literature DB >> 23129158

Getting to better prescription drug information.

Steven Woloshin, Lisa M Schwartz.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23129158      PMCID： PMC3509306          DOI： 10.1007/s11606-012-2222-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  14 in total

1.  Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?

Authors:  S Woloshin; L M Schwartz; J Tremmel; H G Welch
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

2.  Lost in transmission--FDA drug information that never reaches clinicians.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  N Engl J Med       Date:  2009-10-21       Impact factor: 91.245

3.  Communicating data about the benefits and harms of treatment: a randomized trial.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

4.  Evaluation of language concordant, patient-centered drug label instructions.

Authors:  Stacy Cooper Bailey; Urmimala Sarkar; Alice Hm Chen; Dean Schillinger; Michael S Wolf
Journal:  J Gen Intern Med       Date:  2012-03-27       Impact factor: 5.128

5.  Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use.

Authors:  Michael S Wolf; Terry C Davis; Laura M Curtis; Jennifer A Webb; Stacy Cooper Bailey; William H Shrank; Lee Lindquist; Bernice Ruo; Mary V Bocchini; Ruth M Parker; Alastair J J Wood
Journal:  Med Care       Date:  2011-01       Impact factor: 2.983

6.  The drug facts box: providing consumers with simple tabular data on drug benefit and harm.

Authors:  Lisa M Schwartz; Steven Woloshin; H Gilbert Welch
Journal:  Med Decis Making       Date:  2007-09-14       Impact factor: 2.583

7.  The value of benefit data in direct-to-consumer drug ads.

Authors:  Steven Woloshin; Lisa M Schwartz; H Gilbert Welch
Journal:  Health Aff (Millwood)       Date:  2004 Jan-Jun       Impact factor: 6.301

Review 8.  Written information about individual medicines for consumers.

Authors:  Donald Nicolson; Peter Knapp; D K Theo Raynor; Pat Spoor
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  Using a drug facts box to communicate drug benefits and harms: two randomized trials.

Authors:  Lisa M Schwartz; Steven Woloshin; H Gilbert Welch
Journal:  Ann Intern Med       Date:  2009-02-16       Impact factor: 25.391

10.  Usability of FDA-approved medication guides.

Authors:  Michael S Wolf; Jennifer King; Elizabeth A H Wilson; Laura M Curtis; Stacy Cooper Bailey; James Duhig; Allison Russell; Ashley Bergeron; Amanda Daly; Ruth M Parker; Terry C Davis; William H Shrank; Bruce Lambert
Journal:  J Gen Intern Med       Date:  2012-05-08       Impact factor: 5.128
View more
  3 in total

1.  Presenting quantitative information about placebo rates to patients.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Kathryn J Aikin
Journal:  JAMA Intern Med       Date:  2013-11-25       Impact factor: 21.873

2.  Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Kathryn J Aikin
Journal:  Ther Innov Regul Sci       Date:  2015-07       Impact factor: 1.778

3.  Communicative and Discursive Perspectives on the Medication Experience.

Authors:  Lewis H Glinert
Journal:  Pharmacy (Basel)       Date:  2021-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.